Journal of Molecular Medicine
Q1 Journal
Journal
Country
Germany
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Drug Discovery
Q1
└
Genetics (clinical)
Q1
└
Molecular Medicine
Q1
SJR 2025
1.401
Q1
SJR Score
H-Index
167
Citations / Doc (2yr)
4.85
Total Docs. (latest)
103
Total Citations (3yr)
1,702
Publication type
Journals
ISSN
09462716, 14321440
Coverage
1976-1978, 1980-1981, 1995-2026
Journal Rank
#2,759
Subject Categories
Drug Discovery
Q1
Genetics (clinical)
Q1
Molecular Medicine
Q1
Subject Areas
Aims & Scope
The Journal of Molecular Medicine publishes original research articles and review articles that range from basic findings in mechanisms of disease pathogenesis to therapy.
The focus includes all human diseases, including but not limited to:
Aging, angiogenesis, autoimmune diseases as well as other inflammatory diseases, cancer, cardiovascular diseases, development and differentiation, endocrinology, gastrointestinal diseases and hepatology, genetics and epigenetics, hematology, hypoxia research, immunology, infectious diseases, metabolic disorders, neuroscience of diseases, -omics based disease research, regenerative medicine, and stem cell research.
Studies solely based on cell lines will not be considered.
Studies that are based on model organisms will be considered as long as they are directly relevant to human disease.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 103 |
| Total Docs. (3 years) | 345 |
| Total Refs. | 7,227 |
| Total Citations (3 years) | 1,702 |
| Citable Docs. (3 years) | 341 |
| Citations / Doc. (2 years) | 4.85 |
| Ref. / Doc. | 70.17 |
| % Female | 46.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.